TL;DR
- •Adderall discontinuation is NOT antidepressant-style withdrawal — there's no brain-zap, no SSRI-like discontinuation syndrome. Instead, patients experience a "crash": fatigue, low motivation, brain fog, hypersomnia, depression rebound, and increased appetite.
- •The pattern reflects the medication's mechanism — Adderall artificially elevates dopamine and norepinephrine; when removed, the brain's baseline dopaminergic tone temporarily drops below normal until receptor systems re-equilibrate.
- •Tolerance and dose-escalation are common with chronic Adderall use — patients sometimes find the original dose stops working, leading to higher doses and a more difficult discontinuation experience.
- •Drug holidays (intentional weekends or vacations off the medication) are sometimes used to prevent tolerance and characterize how the patient functions without the medication. The crash on the off-days can be a useful preview of full discontinuation.
- •The taper for Adderall is generally less complicated than antidepressant tapers — there's no risk of seizure or severe physical withdrawal — but the psychological component (low energy, depressed mood, executive dysfunction) can be significant for chronic users.
- •For patients with comorbid depression who've been using Adderall partly for its mood-elevating effect, transitioning to ketamine provides a different mood mechanism while ADHD is managed by non-stimulant alternatives or behavioral approaches.
- •Adderall is a Schedule II controlled substance — refills require monthly in-person or telehealth visits with the prescribing physician, and the discontinuation process should be coordinated to avoid abrupt loss of access.
Why people decide to taper
- •Cardiovascular concerns (blood pressure, heart rate, palpitations)
- •Tolerance — the dose no longer produces the original benefit
- •Sleep disruption that's persisted despite dose timing changes
- •Concerns about long-term effects on motivation/dopaminergic function
- •Original ADHD symptoms manageable through other strategies (behavioral, environmental, non-stimulant medications)
- •Pregnancy planning (stimulants carry pregnancy-category C/D considerations)
- •Becoming concerned about dose escalation patterns
What withdrawal looks like
Adderall withdrawal is psychological and physiological but qualitatively different from antidepressant withdrawal. The classic "crash": profound fatigue, hypersomnia, low motivation, depressed mood (sometimes reaching clinical depression severity), brain fog, slowed cognition, increased appetite (often with carb cravings), irritability. Onset is rapid — within 12-24 hours after the last dose because Adderall's half-life is short (~10 hours for immediate-release, longer for XR). The acute crash typically lasts 3-7 days; lingering low mood and reduced motivation can persist for weeks to months for chronic users. There is NO physical withdrawal syndrome — no tremors, no seizures, no autonomic instability characteristic of benzodiazepine or alcohol withdrawal.
Typical taper timeline
Adderall tapers are typically shorter than antidepressant tapers — often 1-4 weeks for short-term users and 4-8 weeks for long-term high-dose users. Some patients can stop abruptly without taper (no seizure risk), but a gradual reduction reduces the crash intensity. Long-term high-dose users (60-100mg/day chronic) often benefit from a slower 2-3 month taper to allow gradual dopaminergic re-equilibration.
Taper approaches
Options to bring to your prescriber. The dose-by-dose plan belongs to your prescriber, not this page.
Linear dose reduction
Reduce by 10-20mg increments every 1-2 weeks. The available IR and XR formulations support reasonable step sizes. Most patients can taper Adderall on this schedule without major withdrawal.
Transition to drug holidays first
Some patients begin with weekend-off or vacation-off patterns to characterize how they function without the medication, then move to permanent discontinuation. This reveals whether the original ADHD symptoms have changed and whether discontinuation is realistic.
Switch to longer-acting formulation before taper
Patients on Adderall IR (immediate release) sometimes benefit from switching to Adderall XR or to Vyvanse (lisdexamfetamine) before tapering — the longer-acting formulations produce smoother plasma kinetics and a less-intense crash between doses.
Add non-stimulant ADHD medication
For patients still needing ADHD treatment, transitioning to non-stimulant alternatives (atomoxetine, guanfacine, viloxazine) before stopping Adderall can provide ongoing symptom control while removing the stimulant. The non-stimulants have no withdrawal profile.
Address comorbid depression with ketamine
For patients with comorbid depression who've been using Adderall partly for mood elevation, ketamine's rapid antidepressant effect addresses the mood component through a different mechanism. This separates the ADHD-treatment question from the depression-treatment question — they can be handled by different medications rather than one stimulant doing both.
What’s specific to Adderall (Amphetamine/Dextroamphetamine)
Adderall combines four amphetamine salts (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, amphetamine sulfate) producing both d-amphetamine and l-amphetamine. The IR formulation has a half-life of ~10 hours; the XR formulation extends this to ~12 hours functional duration. Both are Schedule II — federal controlled substance status means refills are restricted (no automatic refills, monthly prescriber visits typical). Tolerance develops in many patients over months to years of continuous use, manifesting as the original dose producing less effect and prompting dose-escalation discussions. The dopaminergic mechanism is the source of both benefits (executive function, focus) and the crash on discontinuation (temporary dopamine signaling reduction below baseline). Adderall's discontinuation is NOT the dangerous physical-withdrawal profile of benzodiazepines or alcohol — there's no seizure risk — but the psychological and functional impact can be significant. Chronic high-dose use can produce a more prolonged crash and longer recovery curve.
Where ketamine fits
For Adderall patients with comorbid depression — a common pattern where the stimulant is partly treating mood and not just ADHD — ketamine offers a different mechanism for the mood component. The NMDA/glutamate pathway works rapidly (often within hours of the first session) and doesn't produce a crash on discontinuation. This separates the questions: ketamine can handle depression while non-stimulant ADHD treatments (atomoxetine, behavioral strategies) handle the executive-function component. Many Tovani patients have used Adderall partly as a workaround for depression-related fatigue and motivation problems; transitioning the mood component to ketamine often reveals that the ADHD diagnosis was secondary to depression, and the stimulant can be discontinued without major functional impact. For pure ADHD without depression, ketamine isn't the right tool — but for the comorbid pattern, it changes the calculus significantly.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is Adderall withdrawal dangerous?
Not in the way that benzodiazepine or alcohol withdrawal can be dangerous. There's no seizure risk, no autonomic instability, no risk of death from abrupt discontinuation. The "withdrawal" from Adderall is the crash — fatigue, low motivation, depressed mood, brain fog. It's functionally disruptive and can include clinical-severity depression for chronic users, but it's not a medical emergency in the way other classes can be.
How long does the Adderall crash last?
Acute crash: 3-7 days. Lingering low mood and reduced motivation: weeks to months for chronic high-dose users. Short-term users (a few months on the medication) typically recover within 2 weeks. Long-term high-dose users may take 2-3 months to fully re-equilibrate dopaminergic function. The crash is most intense in the first week.
Can I just stop Adderall cold turkey?
You can, in the sense that there's no physical-withdrawal danger — but most patients find a gradual taper less disruptive than abrupt discontinuation. Cold-turkey stops produce the most intense crash. A 2-4 week taper reduces crash intensity meaningfully. For chronic high-dose users, longer tapers are better.
What about depression after stopping Adderall?
Common. Adderall's dopaminergic effect masks underlying depression in some patients — when the medication is removed, the depression that was being incidentally treated becomes apparent. For patients in this pattern, the question shifts from "how do I taper Adderall" to "how do I treat the depression that was being managed by the stimulant." Ketamine, antidepressants, therapy, or combination approaches are all reasonable depending on severity.
I think I need Adderall for ADHD but I want off the stimulant. What are my options?
Non-stimulant ADHD medications: atomoxetine (Strattera), guanfacine (Intuniv), viloxazine (Qelbree), bupropion (off-label for ADHD). These have no withdrawal profile and no addiction potential. Many patients can transition from Adderall to a non-stimulant with prescriber guidance and maintain functional ADHD treatment.
Never taper without prescriber coordination
Withdrawal symptoms can mimic depression or anxiety relapse, and untreated relapse can be more dangerous than withdrawal. Stopping benzodiazepines abruptly can produce seizures. Bring this page to your prescriber as a conversation starter — they translate options into your specific plan.
References
- Ebina T et al. 2026, PCN Reports. ADHD medication discontinuation patterns and withdrawal experiences — characterizes the crash phenomenon distinct from antidepressant discontinuation. PMID 42021984
- Poorvii R et al. 2026, Frontiers in Psychology. Systematic review of cognitive effects of methamphetamine and amphetamine withdrawal — relevant translational evidence for the cognitive/motivational crash that follows stimulant discontinuation. PMID 41969881
- Fries A et al. 2025, Deutsches Arzteblatt International. Clinical overview of stimulant-related emergencies and discontinuation — covers the differential between physiologic and psychological withdrawal patterns. PMID 40991352